Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results.

In conclusion, everolimus-treated patients retained CMV-specific T-cell functionality, which may contribute to enhanced protection against CMV-infections. This article is protected by copyright. All rights reserved.
PMID: 33306229 [PubMed - as supplied by publisher]

Source: European Journal of Immunology - December 11, 2020 Category: Allergy & Immunology Authors: Hauser IA, Marx S, Sommerer C, Suwelack B, Dragun D, Witzke O, Lehner F, Schiedel C, Porstner M, Thaiss F, Neudörfl C, Falk CS, Nashan B, Sester M Tags: Eur J Immunol Source Type: research